2 unknown, 1 completed, 1 recruiting. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Unknown 2, Completed 1, Recruiting 1 |
| Phase 2 | 3 | Unknown 2, Completed 1 |
Follow Thromboangiitis Obliterans: new trials by email Literature Review of Thromboangiitis Obliterans trials Research Report on Thromboangiitis Obliterans
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers ATI-1013 (0.2 g), ATI-1013 (0.8 g), ATI-1013 (3.2 g) - Thromboangiitis Obliterans (Buerger's Disease) | Phase 1 | Recruiting | Antidote Therapeutics, Inc | 15 | 2025-10-01 | 2025-10-15 |
| Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia ADRC injection, ADRC isolation, Liposuction - Critical Limb Ischemia, Arteriosclerosis Obliterans | Phase 1 / Phase 2 | Unknown | Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | 9 | 2016-07-01 | 2016-08-12 |
| Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia ResQ processed bone marrow sample, Ficoll conventional cell processing method - Critical Limb Ischemia, Peripheral Arterial Disease | Phase 1 / Phase 2 | Unknown | Xuanwu Hospital, Beijing | 50 | 2011-10-01 | 2011-10-12 |
| Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb Ischemia Endothelial progenitor cells intramuscular implant - Critical Limb Ischemia | Phase 1 / Phase 2 | Completed | Fondazione IRCCS Policlinico San Matteo di Pavia | 8 | 2009-01-01 | 2012-06-14 |
Chronic Limb-Threatening Ischemia (3) · Peripheral Arterial Disease (2) · Arteriosclerosis Obliterans (1) · Diabetic Angiopathies (1) · Smoking Cessation (1) · Smoking Reduction (1) · Tobacco Use Disorder (1) · Vascular Diseases (1)
Arterial Occlusive Diseases (4) · Cardiovascular Diseases (4) · Vasculitis (4) · Arteriosclerosis (3) · Atherosclerosis (3) · Chronic Disease (3) · Disease Attributes (3) · Ischemia (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Peripheral Vascular Diseases (3) · Vascular Diseases (3) · Behavior (1) · Chemically-Induced Disorders (1) · Diabetes Complications (1)
Cell- and Tissue-Based Therapy (1) · Lipectomy (1)
Antidote Therapeutics, Inc (1) · Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation (1) · Fondazione IRCCS Policlinico San Matteo di Pavia (1) · Xuanwu Hospital, Beijing (1)
China (1) · Italy (1) · Russia (1) · United States (1)
Andrey A Kalinin, MD, PhD (1) · Andrey A Pulin, MD, PhD (1) · Attilio Odero, Professor (1) · Evgeny R Lysenko, MD, PhD, Prof (1) · Matthew Kalnik, PhD (1) · Yong-Quan Gu, Dr. (1)
U01DA058547 (1)